Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSelf-StudyEvaluation, Staging, and Monitoring of Chronic Hepatitis C
Evaluation, Staging, and Monitoring of Chronic Hepatitis C
Sign In or Register to get started
Evaluation, Staging, and Monitoring of Chronic Hepatitis C
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 6 Overview
Surveillance for Hepatocellular Carcinoma - 0%Topic 1
EpidemiologyActivities- 0%Topic 2
Risk Factors and PrognosisActivities- 0%Topic 3
Benefit of HCC Surveillance with HCV InfectionActivities- 0%Topic 4
Indications for HCC SurveillanceActivities- 0%Topic 5
Surveillance Testing MethodsActivities- 0%Topic 6
Guidance for HCC SurveillanceSurveillance for Hepatocellular Carcinoma Overview
About this Lesson
Last Updated: April 6th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: July 1st, 2013CNE and CME Review: April 11th, 2024CNE and CME Expiration: April 10th, 2027 (4th Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Surveillance for Hepatocellular Carcinoma and available until April 11th, 2024.Learning Objectives
- Discuss the incidence of hepatocellular carcinoma (HCC) in persons with chronic HCV
- Describe major risk factors for developing HCC
- Explain the rationale for HCC surveillance in persons with chronic HCV infection
- Summarize the American Association for the Study of Liver Diseases (AASLD) recommendations for HCC surveillance indications
- List recommended HCC surveillance methods
Lesson Contributors
Authors
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Funded byCenters for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)Created at University of WashingtonPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE provided byUniversity of Washington School of NursingCopyright © 2024 Hepatitis C OnlineSince you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-9e0a1e65-2024-12-09-232944 - 0%Topic 2